Standout Papers

Donanemab: First Approval 2024 202625
  1. Donanemab: First Approval (2024)
    Connie Kang Drugs

Immediate Impact

2 from Science/Nature 54 standout
Sub-graph 1 of 23

Citing Papers

Regulation of the cGAS-STING Pathway
2025 Standout
Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
2 intermediate papers

Works of Connie Kang being referenced

Avacincaptad Pegol: First Approval
2023
Atezolizumab (in Combination with Nab-Paclitaxel): A Review in Advanced Triple-Negative Breast Cancer
2020

Author Peers

Author Last Decade Papers Cites
Connie Kang 316 60 191 207 55 879
Weihua Chen 386 127 108 153 90 1.1k
Leiming Xu 344 112 180 245 42 950
Kaiwen Hu 250 141 176 128 74 831
Changhoon Choi 433 163 246 95 54 933
Aiqun Liu 369 64 247 104 57 819
Chun‐Chia Cheng 407 134 254 150 53 1.1k
Xiaobo Hu 341 67 71 167 54 784
Zheng Han 365 91 202 148 50 907
Huanrong Lan 455 149 417 163 60 1.1k
Hai Zhu 518 119 129 134 64 1.2k

All Works

Loading papers...

Rankless by CCL
2026